o 129 has been researched along with 2,4,6-triaminopyrimidine in 1 studies
Studies (o 129) | Trials (o 129) | Recent Studies (post-2010) (o 129) | Studies (2,4,6-triaminopyrimidine) | Trials (2,4,6-triaminopyrimidine) | Recent Studies (post-2010) (2,4,6-triaminopyrimidine) |
---|---|---|---|---|---|
30 | 0 | 2 | 38 | 0 | 15 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gibson, CL; Huggan, JK; Hunter, WN; Iulek, J; Lee, JH; Martini, VP; Smith, TK; Suckling, CJ; Tulloch, LB | 1 |
1 other study(ies) available for o 129 and 2,4,6-triaminopyrimidine
Article | Year |
---|---|
Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
Topics: Catalytic Domain; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Leishmania major; Leishmaniasis; Models, Molecular; Molecular Structure; Oxidoreductases; Parasitic Sensitivity Tests; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Trypanosoma brucei brucei; Trypanosomiasis, African | 2010 |